-
POTENTIAL IMPACT OF U.S MFN PRICING ON EX-US PRODUCT LAUNCH AND WITHDRAWAL STRATEGIES
Aug 11, 2026, 17:16 PM -
MEETING REGULATORY TARGETS, MISSING REIMBURSEMENT: EVIDENCE OF A SYSTEMATIC ENDPOINT MISMATCH IN PULMONARY ARTERIAL HYPERTENSION
Aug 11, 2026, 17:16 PM -
THRESHOLD SENSITIVITY ANALYSIS OF ADJUVANT TRASTUZUMAB IN HER2-POSITIVE EARLY BREAST CANCER IN INDIA
Aug 11, 2026, 17:16 PM -
ADDRESSING EQ-5D CEILING EFFECTS THROUGH A DISEASE-SPECIFIC SYMPTOM THRESHOLD: A PATIENT-LEVEL ANALYSIS INFORMING THE NICE APPRAISAL OF DUPILUMAB IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Aug 11, 2026, 17:16 PM -
THE INVISIBLE BURDEN OF GLIOBLASTOMA - COMBINING LITERATURE REVIEW WITH PATIENT AND CAREGIVER QUALITATIVE INSIGHTS
Aug 11, 2026, 17:16 PM -
DEVELOPMENT OF AN INTEGRATED FRAMEWORK AND AI-ASSISTED PLATFORM FOR COMPLIANT AND SCALABLE REAL-WORLD EVIDENCE GENERATION USING REGIONAL HEALTHCARE DATA IN CHINA
Aug 11, 2026, 17:16 PM -
ECONOMIC BURDEN OF DIABETES COMPLICATIONS IN ALGERIA: A REAL-WORLD BUDGET IMPACT ANALYSIS
Aug 11, 2026, 17:16 PM -
ECONOMIC EVALUATION OF FENOFIBRATE FOR REDUCING THE PROGRESSION OF DIABETIC RETINOPATHY IN THAILAND
Aug 11, 2026, 17:16 PM -
DISEASE BURDEN AND HEALTHCARE UTILIZATION AFTER DIAGNOSIS OF NEUROFIBROMATOSIS TYPE 1 AND PLEXIFORM NEUROFIBROMAS (NF1-PN) IN SWEDISH PEDIATRIC PATIENTS: A REGISTRY-BASED STUDY
Aug 11, 2026, 17:16 PM -
CLINICAL AND ECONOMIC EVALUATION OF ASFOTASE ALFA FOR PEDIATRIC-ONSET HYPOPHOSPHATASIA IN KAZAKHSTAN
Aug 11, 2026, 17:16 PM -
REPRESENTATIVENESS OF IQVIA MEDICAL RESEARCH DATA: A MULTI-DOMAIN ASSESSMENT AGAINST NATIONAL DEMOGRAPHIC, MORTALITY AND DISEASE BENCHMARKS IN ENGLAND
Aug 11, 2026, 17:16 PM -
JOINT ASSOCIATIONS OF CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME AND DEPRESSIVE SYMPTOMS WITH INCIDENT FRAILTY: THE MEDIATING ROLE OF BODY ROUNDNESS INDEX
Aug 11, 2026, 17:16 PM -
THE CLINICAL AND HUMANISTIC IMPACT OF PEMBROLIZUMAB IN THE CZECH REPUBLIC: A POPULATION-LEVEL PAN-TUMOR MODELING STUDY
Aug 11, 2026, 17:16 PM -
A MATCH-ADJUSTED INDIRECT COMPARISON (MAIC) OF EFFICACY OUTCOMES BETWEEN LIFILEUCEL AND IPILIMUMAB (IPI) IN ANTI-PD1 RESISTANT ADVANCED MELANOMA
Aug 11, 2026, 17:16 PM -
DIFFERENCES IN SOCIAL RISK, MENTAL HEALTH, AND CLINICAL PROFILES AMONG ADULTS WITH OBESITY TREATED WITH GLP-1 VERSUS NON-GLP-1 ANTI-OBESITY MEDICATIONS USING REAL-WORLD DATA
Aug 11, 2026, 17:16 PM -
REAL-WORLD PERSISTENCE WITH LIRAGLUTIDE (SAXENDA) FOR WEIGHT MANAGEMENT IN ADULT PATIENTS
Aug 11, 2026, 17:16 PM -
CAN THE EQ-5D-5L DETECT MEANINGFUL CHANGES FOR HEALTHCARE DECISION MAKING? A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
PREDIABETES: FROM RISK TO REVERSAL—OUTCOMES AND GLYCEMIC PREDICTORS AFTER A 12-MONTH LIFESTYLE INTERVENTION
Aug 11, 2026, 17:16 PM -
TRANSFORMING THE ASSESSMENT OF UNCERTAINTY IN HEALTH ECONOMIC MODELS USING GENERATIVE AI
Aug 11, 2026, 17:16 PM -
PREFERENCES OF PEOPLE LIVING WITH HIV FOR INJECTABLE VERSUS ORAL ANTIRETROVIRAL THERAPY (ART): A DISCRETE CHOICE EXPERIMENT (DCE) ACROSS CHINA, US, UK, SPAIN, AND GERMANY
Aug 11, 2026, 17:16 PM
